Purdue makes new offer to settle role in opioid crisis

Washington (AFP) – US drugmaker Purdue Pharma filed a new bankruptcy plan that would see its founders pay an additional $1.5 billion to settle the company’s role in the devastating opioid crisis. The offer made in a restructuring plan filed late on Monday was rejected by two dozen state attorneys general, who said it falls short. “We are disappointed in this plan. While it contains improvements over the proposal that Purdue announced and we rejected in September 2019, it falls short of the accountability that families and survivors deserve,” the state officials said in a joint statement. Purdu…

Read More

HEDGE accordingly